Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01189552 · ClinicalTrials.gov registry record · NA
Depression Treatment for Low Income Substance Users
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 263
- Enrollment target
NCT01189552 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 263 participants.
The verdict
NCT01189552, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
Study Summary
The objective of the current study is to evaluate the effects of a brief, behavioral activation treatment (the Life Enhancement Treatment for Substance Use; LET'S ACT) on long term outcomes of substance use, HIV risk behaviors and mechanisms of treatment response (depressive symptoms, environmental reward, behavioral activation).
Interventions
- BEHAVIORAL Nondirective Therapy (NDT)
- BEHAVIORAL LETS ACT Behavioral Activation Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01189552
The ClinicalTrials.gov registry entry for NCT01189552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nondirective Therapy (NDT) is the first listed.
NCT01189552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01189552 about?
NCT01189552 is a clinical study titled "Depression Treatment for Low Income Substance Users". The objective of the current study is to evaluate the effects of a brief, behavioral activation treatment (the Life Enhancement Treatment for Substance Use; LET'S ACT) on long term outcomes of substance use, HIV risk behaviors and mechanisms of treatment response (depressive symptoms, environmental ...
What is the current status of trial NCT01189552?
This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2010-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01189552?
The interventions under investigation include: Nondirective Therapy (NDT) (BEHAVIORAL), LETS ACT Behavioral Activation Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01189552?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.